Source: Eur Respir J, 58 (1) 2003862; 10.1183/13993003.03862-2020
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Kevin M. Magnaye, Katherine A. Naughton, Janel Huffman, D. Kyle Hogarth, Edward T. Naureckas, Steven R. White, Carole Ober. A-to-I editing of miR-200b-3p in airway cells is associated with moderate-to-severe asthma. Eur Respir J, 58 (1) 2003862; 10.1183/13993003.03862-2020

Member's Comments

No comment yet.

Related content which might interest you: Proto-oncogenes expression in airway remodelling in asthma Source: Eur Respir J 2001; 18: Suppl. 33, 159s Year: 2001 The expression of CD39 mRNA is altered in peripheral blood of patients with allergic asthma Source: Annual Congress 2013 –Genetics and mechanisms of, and tests for, allergy Year: 2013 DPP10 protein expression is associated with the pathogenesis of asthma and COPD Source: Eur Respir J 2005; 26: Suppl. 49, 231s Year: 2005 The potential of epigenetic editing in chronic lung disease Source: International Congress 2018 – Organoids and pluripotent stem cells Year: 2018 Neovascularisation in asthma: Altered angiogenic potential of ASM cells from asthmatic patients Source: Annual Congress 2012 - Molecular biology of pro- and anti-inflammatory responses in the lung Year: 2012 Characterisation and mRNA expression analysis of the bronchial hyperresponsiveness susceptibility gene protocadherin-1 in asthma patients Source: Annual Congress 2009 - New results in molecular pathology and functional genomics of non-neoplastic lung diseases Year: 2009 Improvement of allergic asthma symptoms by targeting STAT6 with siRNA Source: Annual Congress 2008 - New mechanisms in the pathogenesis of asthma and its response to treatment Year: 2008 The development of an allergic airway disease is influenced by a short splice variant of CYLD Source: Annual Congress 2010 - Animal models of asthma and lung inflammation Year: 2010 Significance of microRNAs in allergic asthma patients. Source: International Congress 2017 – Asthma genetics and genomics in patients and populations Year: 2017 Are asthma and COPD translation control diseases? Translational defect of cell cycle regulators C/EBP-α and -δ in airway smooth muscle cells (ASMC) of patients with asthma and COPD Source: Eur Respir J 2005; 26: Suppl. 49, 20s Year: 2005 Relative corticosteroid insensitivity in human airway smooth muscle cells from severe asthma patients in terms of transrepression not transactivation Source: Annual Congress 2010 - Airway smooth muscle cells Year: 2010 Targeting the epigenome in asthma and COPD Source: Annual Congress 2013 –PG6 Epigenetics of asthma and COPD Year: 2013 DNA methylation modules in airway smooth muscle are associated with asthma severity Source: Eur Respir J, 51 (4) 1701068; 10.1183/13993003.01068-2017 Year: 2018 T regulatory cells decrease before asthma exacerbations Source: Annual Congress 2008 - Understanding the mechanisms and the impact of severe asthma Year: 2008 Distinct epithelial gene expression phenotypes in childhood respiratory allergy Source: Eur Respir J 2012; 39: 1197-1205 Year: 2012 Gamma/delta T cells regulate airways disease during rhinovirus-induced asthma exacerbations Source: Annual Congress 2011 - Insight into mechanisms of respiratory infections Year: 2011 microRNA–mRNA regulatory networks underlying chronic mucus hypersecretion in COPD Source: Eur Respir J, 52 (3) 1701556; 10.1183/13993003.01556-2017 Year: 2018 Downregulation of the pro-apototic gene, BNIPL, in bronchial biopsies from COPD patients Source: ERS Lung Science Conference 2017 Year: 2017 Airway remodelling augmented in patients with asthma COPD overlap (ACO) compared to asthma and COPD. Source: Virtual Congress 2021 – Novel insights into the pathogenesis of chronic lung diseases Year: 2021